Topic: United Kingdom

Two antidepressants ineffective for dementia: study

HONG KONG (Reuters) - Two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness, a study in Britain has found.In a paper published in the medical ...

Study finds two antidepressants ineffective for dementia

HONG KONG (Reuters) - Two antidepressants that are commonly given to Alzheimer's disease patients appear not only to be ineffective but may give side effects such as nausea and drowsiness, a study in Britain has found.In a paper published in the medical ...

UK cost agency to extend use of Alzheimer's drugs

LONDON (Reuters) - Britain's health costs agency has confirmed a plan to end restrictions on the use by the National Health Service (NHS) of some Alzheimer's medicines, a change that should allow hundreds of thousands of new patients to get the drugs ...

Colostrinin

Colostrinin (also known as CLN , proline-rich polypeptides or PRP ) is a naturally occurring mixture of proline -rich polypeptides derived from colostrum . The form used for human consumption is isolated from bovine colostrum by UK-based ReGen Therapeutics Plc.Colostrinin was originally ...
For our parents and grandparents, Alzheimer's disease made the end of life feel like a game of Russian roulette. The National Institute on Aging reports that 4.5 million Americans are estimated to have Alzheimer's . Fortunately for the current generation, we are ...

Alzheimers-A Mean Disease

I call it a mean disease, because it affects not only those who have the disease, but those who live with and care for the Some days my mother knows who she is. According to statistics, at least one of two families ...
Considered as the 'biggest break-through in 15 years' the UK discovery of 3 potential key genes could help cut the number of people developing Alzheimers by up to a fifth, claim the Alzheimer's Research Trust. In fact adults over 50 are now ...

UK cost agency to end curbs on Alzheimer's drugs

LONDON (Reuters) - Britain's healthcare cost agency plans to end controversial restrictions on Alzheimer's drugs in a policy U-turn that could give hundreds of thousands of patients access to previously denied medicines.The National Institute for Health and Clinical Excellence (NICE) said on ...
The effect of directly or indirectly targeting tau proteins, which lead to the formation of neurofibrillary tangles in Alzheimer's disease, remains unclear. However, three studies presented at the Alzheimer's Association International Conference on Alzheimer's Disease, held from July 10 to 15 in ...

Treating Alzheimers disease

The article focuses on the treatment of Alzheimer's disease among adults in Great Britain. The National Institute for Clinical Excellence (NICE) recommends inhibitors donepezil, galantamine and rivastigmine as options in managing the patients. com EDUCATION 2 JOURNALS CLUB Treating Alzheimer's disease CURRICULUM ...
Previous